David R. Rubinow

ORCID: 0000-0003-0815-2263 · 12 papers in corpus
other 2024
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology ·doi:10.1038/s41386-023-01687-0

The hormonal changes of pregnancy and parturition can trigger robust changes in affective state, particularly among patients with a history of postpartum depression. However, more work is needed to elucidate the temporal dynamics of symptom…

2020
·doi:10.17615/pd7h-xt93

Selective serotonin reuptake inhibitors (SRIs) relieve irritability within days in women with premenstrual dysphoric disorder (PMDD); however, the effects on other affective symptoms in PMDD remain to be demonstrated.

rct 2020
Archives of women's mental health ·doi:10.1007/s00737-019-00991-3

Postpartum depression (PPD) is a common complication following delivery, though evidence-based treatment options are limited. This study explores the feasibility and efficacy of outpatient PPD treatment with transdermal estradiol (TE). In a…

rct 2017
Depression and anxiety ·doi:10.1002/da.22673

BACKGROUND: Although traditionally dosed combined oral contraceptives (COCs) (21 days of active pills, 7 days of inactive pills) have not been demonstrated as superior to placebo for the treatment of premenstrual dysphoria (PMD), some rando…

nonrandomized-trial 2016
Neuropsychologia ·doi:10.1016/j.neuropsychologia.2015.12.021

BACKGROUND: Despite well-established sex differences in the performance on tests of several cognitive domains (e.g., visuospatial ability), few studies in humans have evaluated if these sex differences are evident both in the presence of ci…

nonrandomized-trial 2013
Archives of women's mental health ·doi:10.1007/s00737-012-0316-9

Gynecology clinic-based studies have consistently demonstrated that induced hypogonadism is accompanied by a decline in cognitive test performance. However, a recent study in healthy asymptomatic controls observed that neither induced hypog…

other 2013
The American journal of psychiatry ·doi:10.1176/appi.ajp.2012.12010117

OBJECTIVE: The relationship between depression and estrogen withdrawal remains controversial. The authors examined the effects of gonadotropin-releasing hormone agonist-induced ovarian suppression on mood, sleep, sexual function, and nightt…

observational 2010
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2010-0613

CONTEXT: A high prevalence of depressive symptoms is observed in women with primary ovarian insufficiency (POI) compared with women in whom the menopause is normally timed. Indeed, studies suggest that depression and/or its pharmacological …

observational 2010
·doi:10.1210/edrv.31.6.9990

Context A high prevalence of depressive symptoms is observed in women with primary ovarian insufficiency (POI) compared with women in whom the menopause is normally timed. Indeed, studies suggest that depression and/or its pharmacological t…

observational 2010
·doi:10.1210/endo.151.12.9992

Context: A high prevalence of depressive symptoms is observed in women with primary ovarian insufficiency (POI) compared with women in whom the menopause is normally timed. Indeed, studies suggest that depression and/or its pharmacological …

observational 2004
The American journal of psychiatry ·doi:10.1176/appi.ajp.161.12.2238

OBJECTIVE: Mood and reproductive function were prospectively evaluated in asymptomatic premenopausal women to determine whether the onset of depression was temporally linked to the perimenopause. METHOD: Twenty-nine asymptomatic, regularly…

review 2002
Dialogues in clinical neuroscience ·doi:10.31887/dcns.2002.4.2/pschmidt

There has been a century-long view in medicine that reproductive function in both men and women is intimately involved with mood regulation. The 19th century witnessed a proliferation of medical reports documenting beneficial effects on moo…